Hims & Hers Health Inc.（HIMS）今日盘前股价大幅上涨38.56%，引起了市场的广泛关注。
消息面上，此次股价异动与公司的一项重大商业合作进展直接相关。据知情人士透露，全球制药巨头诺和诺德计划在Hims & Hers Health的平台上销售其减肥药，此举将终结两家公司之间一场高度公开的纠纷，该纠纷在上月曾升级为法律诉讼。新的合作关系最早可能于下周初正式宣布。
这一合作意味着Hims & Hers Health将获得诺和诺德这一重磅减肥药产品的销售渠道，有望为公司带来显著的营收增长机会，并消除了此前因法律纠纷带来的不确定性，从而极大地提振了市场信心。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.